
Case Report Highlights the Importance of Post Market Drug Safety Monitoring in Duchenne Muscular Dystrophy Patients
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOSWNsYTR5d3VHdEZMczZIdWYydFFsQzVzNW8tYTByOFBaR0c0LVlGS0xfaUZFd1l6RWgtM3QyNHJ4WUkyVmF6cUI0UHpsVE1ucG01aVdSN0tXaEt4YW8zTXRwTEhFWTVMYTdHdzdYS09HbmhTUzk4MGx0U202eDdtMWFWSDZpbFdfSGszQ2dxZkY0Y0w4X3I2M251OGVqMFpoRXFyUTBuOEtzcVVQQi1SNjR3?oc=5" target="_blank">Case Report Highlights the Importance of Post Market Drug Safety Monitoring in Duchenne Muscular Dystrophy Patients</a>&nbsp;&nbsp;<font color="#6f6f6f">Children's Hospital of Philadelphia</font>

